0000899243-21-025140.txt : 20210621
0000899243-21-025140.hdr.sgml : 20210621
20210621202242
ACCESSION NUMBER: 0000899243-21-025140
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210617
FILED AS OF DATE: 20210621
DATE AS OF CHANGE: 20210621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Van Hauwermeiren Timothy
CENTRAL INDEX KEY: 0001816206
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39401
FILM NUMBER: 211032694
MAIL ADDRESS:
STREET 1: C/O ITEOS THERAPEUTICS, INC.
STREET 2: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: iTeos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001808865
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 857-204-4583
MAIL ADDRESS:
STREET 1: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-17
0
0001808865
iTeos Therapeutics, Inc.
ITOS
0001816206
Van Hauwermeiren Timothy
C/O ITEOS THERAPEUTICS, INC.
139 MAIN STREET
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (Right to Buy)
26.03
2021-06-17
4
A
0
16608
0.00
A
2031-06-17
Common Stock
16608
0
D
This stock option shall vest and become exercisable in full upon the earlier to occur of (a) June 17, 2022 or (b) the next annual meeting of the Issuer's stockholders.
/s/ Michel Detheux, as Attorney-in-Fact
2021-06-21